Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia—13-year study

doi:10.1016/0021-9681(83)90169-8

Journal of Chronic Diseases

Volume 36, Issue 5, 1983, Pages 371-377

Journal of Chronic D...

https://doi.org/10.1016/0021-9681(83)90169-8 Get rights and content

Abstract

The mortality of 1564 Busselton subjects has been studied from 66–79 to determine whether0 risk factors for cardiovascular disease (CVD) and coronary heart disease (CHD) showed any change in emphasis compared with the Framingham Population Study of 20 yr previously. The Busselton analysis used subjects free of probable and suspect coronary heart disease at onset. In men aged 40–59, systolic blood pressure (SBP), forced expiratory volume (FEV), and serum cholesterol levels were significant independent determining variables for CVD mortality and cholesterol for CHD mortality, with SBP being related to CVD in men aged 60–74 yr. In women, there were few indicators of future vascular risk with no significant determining variable for CVD and CHD in 40–59 yr olds, but blood glucose and FEV were significant risk factors for CVD in women aged 60–74 yr. Cholesterol was unrelated to mortality in women but showed negative relationship with cancer in 60–74 yr old men.

In total mortality, smoking in men and women, and obesity in women were significant risk factors; 1 hr serum insulin had a negative relationship in men aged 40–59 yr, and a stronger positive relationship in men aged 60–74 yr, but this may have been due to the close negative association of the variable with body size (i.e. height). More studies are required to ascertain whether glucose and insulin have an aetiological role in vascular disease.

References (18)

KJ Cullen et al.
Chronic respiratory disease in a rural community
Lancet
(1968)
MF Oliver
Serum cholesterol—the knave of hearts and the joker
Lancet
(1981)
H Kesteloot et al.
Calcium and blood pressure
Lancet
(1982)
DH Curnow et al.
Health and disease in a rural community—a Western Australia study
Aust J Sci
(1969)
TA Welborn et al.
The prevalence of coronary heart disease and associated factors in an Australian rural community
Am J Epid
(1969)
KJ Cullen et al.
Changing mortality due to strokes in men following treatment of Busselton hypertensives 66–77
Int J Epid
(1979)
KJ Cullen et al.
Community medicine in Busselton
Practitioner
(1981)
GA Rose et al.
Cardiovascular survey methods
H Blackburn et al.
The electrocardiogram in population studies. A classification system
Circulation
(1960)

There are more references available in the full text version of this article.

Cited by (128)

Association of fasting serum insulin and cancer mortality in a healthy population – 28-year follow-up of the French TELECOM Study
2018, Diabetes and Metabolism
Citation Excerpt :
However, the link between fasting serum insulin and death by cancer is still subject to discussion in the light of the few prospective epidemiological studies available [19–23]. These studies concluded to either a lack of association, a too small sample size [20–22], or higher cancer mortality for higher insulin values [19,23]. The two articles giving detailed data found that the risk was lowest for average values of fasting serum insulin, suggesting a J- or U-shape relationship between insulin exposition and cancer death [20,21].
Epidemiologic, pharmacoepidemiologic and pathophysiologic evidence points consistently to an association between type 2 diabetes and cancer. This association could be explained by hyperinsulinemia induced by insulin resistance. We studied the association between fasting serum insulin (FSI) and cancer mortality in a population of non-diabetic individuals.
We followed 3117 healthy workers (50.2% women), included in the TELECOM cohort study, between 1985 and 1987; their median age was 38 years (Q1–Q3 = 30–50). Baseline FSI was measured by radioimmunoassay, the INSI-PR method. People with diabetes or cancer at baseline were excluded. Vital status and causes of death were available until December 2013. The association between FSI and cancer deaths was analysed by sex, using a Cox proportional hazards model with age as the time scale, adjusting for body mass index, smoking habits, alcohol consumption, occupational category and ethnic origin.
After a 28-year follow-up, 330 (10.6%) deaths were reported, among which, 150 were cancer-related (80 men, 70 women). In men, the association between FSI and death by cancer was J-shaped: compared to the average FSI of 7.1 mU/L, men with 5 mU/L and 12.9 mU/L had respectively adjusted hazard-ratios (HR) of 1.88 (95% confidence interval, 1.00–3.56) and 2.30 (95% CI, 1.34–3.94). Among women, no significant association was found (adjusted HR, 1.03; 95% CI, 0.96–1.11) for an increase of 1 mU/L in FSI.
These results strengthen the hypothesis of an independent risk of cancer death associated with extreme values of FSI, mainly the highest, among men, but not among women.
A comparison of small-area hospitalisation rates, estimated morbidity and hospital access
2015, Health and Place
Citation Excerpt :
Viil-Kajander et al. (2003) focussed specifically on Finland but also found that men were more at risk of coronary heart disease, especially middle aged men. These same results were also found by Franco et al. (2011), Fodor and Tzerovska (2004), Gottdiener et al. (2000), Esrey et al. (1996); Kannel et al. (1986) and Cullen et al. (1983). Table 1 shows social class to be a significant explanatory variables for heart disease.
Published data on hospitalisation rates tend to reveal marked spatial variations within a city or region. Such variations may simply reflect corresponding variations in need at the small-area level. However, they might also be a consequence of poorer accessibility to medical facilities for certain communities within the region. To help answer this question it is important to compare these variable hospitalisation rates with small-area estimates of need. This paper first maps hospitalisation rates at the small-area level across the region of Yorkshire in the UK to show the spatial variations present. Then the Health Survey of England is used to explore the characteristics of persons with heart disease, using chi-square and logistic regression analysis. Using the most significant variables from this analysis the authors build a spatial microsimulation model of morbidity for heart disease for the Yorkshire region. We then compare these estimates of need with the patterns of hospitalisation rates seen across the region.
Secondhand Smoke Exposure, Pulmonary Function, and Cardiovascular Mortality
2007, Annals of Epidemiology
Citation Excerpt :
This traditional view of SHS exposure and cardiovascular disease, however, may oversimplify the causal pathway and result in biased estimates of its effects. Forced expiratory volume in 1 second (FEV1) has been established as an important predictor of cardiovascular mortality (12–21). Although the exact mechanism for this association is unknown, FEV1 is likely to capture important biological processes that are unaccounted for by traditional cardiovascular risk factors.
Cardiovascular disease and obstructive lung disease are leading global causes of death. Despite this, the impact of secondhand smoke (SHS) exposure on pulmonary function and cardiovascular disease remains uncertain. Our goal was to elucidate the association between baseline SHS exposure and the risk of lung function decline and cardiovascular mortality over a period of nearly a decade.
We used data from a longitudinal cohort study of 1,057 older adults to study the association between baseline SHS exposure and the risk of lung function decline and cardiovascular mortality. The effect of SHS exposure on cardiovascular mortality may be mediated by its influence on FEV₁ and biological processes captured by measurement of FEV₁. Alternatively, the effect of SHS may be mediated by baseline cardiovascular disease status, which reflects the combined effects of traditional cardiovascular risk factors. To correctly estimate the effect of SHS and FEV₁ on cardiovascular mortality, we used marginal structural models (MSMs) that took into account the mediating effects of FEV₁ and baseline cardiovascular disease in the causal pathway.
In longitudinal multivariate analyses, lifetime cumulative home and work SHS exposure were associated with a greater decline of FEV₁ (−15 mL/s; 95% CI, −29 to −1.3 mL/s and −41 mL/s; 95% CI, −55 to −28 mL/s per 10-year cumulative exposure, respectively). Lifetime home SHS exposure was associated with a greater risk of cardiovascular mortality in both conventional multivariate analysis (HR, 1.10 per 10 years of exposure; 95% CI, 0.99 to 1.24) and the MSM for FEV₁ (HR, 1.06; 95% CI, 0.95 to 1.19) and baseline cardiovascular disease (HR for subjects with no baseline cardiovascular disease, 1.39; 95% CI, 1.17 to 1.66).
Lifetime SHS exposure appears to result in a greater decline in lung function and risk of cardiovascular mortality, taking into account confounders and the mediating effect of FEV₁ and baseline cardiovascular disease.
The Value of Forced Expiratory Volume in 1 Second Decline in the Assessment of Chronic Obstructive Pulmonary Disease Progression
2006, American Journal of Medicine
Forced expiratory volume in 1 second (FEV₁) declines normally with aging by approximately 30 mL/yr, but in susceptible smokers, the decline is greater (about 60 mL/yr), resulting in the development of chronic obstructive pulmonary disease (COPD). Smoking cessation usually restores the normal or near-normal rate of FEV₁ decline, whereas intermittent quitting provides less benefit. Thus, smoking cessation is a critical component for the prevention of COPD progression. FEV₁ is central to the definition of COPD and classification of its severity. FEV₁ is a good predictor of exercise tolerance and correlates with survival and quality of life. More rapid FEV₁ decline is also predictive of morbidity, mortality, and hospitalization rates. Risk factors for accelerated decline in FEV₁, in addition to smoking, include frequent exacerbations, airways reactivity, and possibly chronic systemic inflammation. Genetic components of the decline in FEV₁ are being actively explored, but none has been extensively validated other than α₁-antitrypsin deficiency. To date, only smoking cessation has been definitively shown to be effective in reducing the rate of FEV₁ decline, but other therapeutic strategies are under active research. Consequently, FEV₁ and its change over time are important outcomes in COPD and valuable measures for the assessment of disease progression.
Can global initiative for chronic obstructive lung disease stage 0 provide prognostic information on long-term mortality in men?
2006, Chest
Citation Excerpt :
The present study adjusted for an objective measure of physical fitness, and it should be noted that none of the above studies have adjusted for an objective measure of physical fitness, known to be associated with various coronary risk factors43 and reduced mortality.444546 That the more advanced GOLD stages predicted all-cause mortality was no surprise, as the definition of these groups are based on the FEV1, a well-known predictor of mortality.345678910111213141516 The major limitation of this study is the limited number of individuals in GOLD stage 0 reducing the power of the study.
To determine if the Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage 0 (subjects at risk for COPD) provides information about long-term mortality risk.
From 1972 to 1975, clinical, physiologic, and biochemical parameters including respiratory symptoms, spirometry, and physical fitness were measured in 1,999 healthy men aged 40 to 59 years in an occupational cohort, of whom 1,623 had acceptable spirometry findings. In a proportional hazards model with follow-up until 2000, we assessed all-cause mortality according to GOLD stage 0, I, II, and III compared with “normal” subjects, after adjusting for known risk factors and potential confounders.
After 26 years (range, 25 to 27 years), 615 men (38%) had died. In multivariate proportional hazards models, GOLD stage 0 subjects had a nonsignificantly increased hazard of death (hazard ratio [HR], 1.19; p = 0.21) after adjustment for age, smoking, physical fitness, body mass index, systolic BP, and serum cholesterol. Similarly, subjects in GOLD stage I (HR, 1.30; p = 0.05) and stage II (HR, 1.77; p < 0.0001) had increased all-cause mortality. When expanding GOLD stage 0 to comprise patients with any respiratory symptom in a sensitivity analysis, the HR for all-cause mortality increased (HR, 1.35; p = 0.03).
There probably is an excess mortality among GOLD stage 0 subjects compared to symptom-free subjects; however, this should be interpreted cautiously and the results vary with the definition of the GOLD stage 0. Subjects in GOLD stage I or stage II had higher mortality than symptom-free subjects.
Peritoneal Dialysis in Diabetic End-Stage Kidney Disease
2023, Nolph and Gokal’s Textbook of Peritoneal Dialysis: Fourth Edition

View all citing articles on Scopus

View full text

Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia—13-year study

Abstract

Lancet

Lancet

Lancet

Health and disease in a rural community—a Western Australia study

Aust J Sci

The prevalence of coronary heart disease and associated factors in an Australian rural community

Am J Epid

Changing mortality due to strokes in men following treatment of Busselton hypertensives 66–77

Int J Epid

Community medicine in Busselton

Practitioner

Cardiovascular survey methods

The electrocardiogram in population studies. A classification system

Circulation